Ozempic counterfeit ring charges against Indian nationals unsealed

Key Points:

• Two Indian nationals, Swapnadip Roy and Vicky Ramancha, have been charged in Florida federal court for allegedly conspiring to smuggle counterfeit Ozempic from China, continuing their scheme even after FDA seizures and warnings in 2023.
• Roy, 33, was extradited from Italy and appeared in court in Tampa, while Ramancha, 37, remains at large; both face charges including conspiracy, smuggling, and selling counterfeit drugs with potential sentences up to 71 years.
• The indictment alleges that from July 2023 to April 2024, the men distributed fake Ozempic with counterfeit packaging and materials to deceive customers, including executing sales agreements with Florida companies at deeply discounted prices.
• Court documents reveal threatening communications from Roy to facilitate distribution and indicate the defendants continued operations despite FDA seizures and warnings, highlighting the risks posed by counterfeit prescription drugs.
• The case emerges amid rising use of GLP-1 medications like Ozempic for weight loss in the U.S., with Gallup reporting an increase from 3% to 11% of adults using these drugs between 2024 and 2026, raising concerns over public health and pharmaceutical supply integrity.